您现在的位置是:风核传媒 > 焦点
Weight regain happens 4x faster after stopping GLP
风核传媒2026-02-01 02:19:28【焦点】0人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(34694)
上一篇: 邵逸夫奖历史性增设计算机科学奖
热门文章
站长推荐
友情链接
- 王者荣耀s39新赛季五大更新是什么 s39新赛季五大更新内容介绍
- 6.9万人参与,分类正确率达85%,试点定时定点投放,平湖是如何做到的……
- 没有塔图姆,还有塔秃姆
- 盘点东京奥运会那些绝佳的环保发明设计!-
- F1车队平均估值达34.2亿美元
- 恶魔秘境丛林猎手500魂地狱黑塔攻略
- 人教版七年级上册六单元作文:人类起源概说
- 湖北卫视聚焦膜技术典型项目
- 《乌龙派出所》迎接诞生50周年 新策划《新乌龙派出所》公布
- 中粮油脂旗下中粮东海粮油工业(张家港)有限公司新建15万吨筒仓项目竣工投用
- 这些有创意的国外垃圾桶设计 净化周边地面环境
- [新浪彩票]足彩第25190期任九:利物浦保平争胜
- 换电老兵冲刺港股上市 换电模式(站)有望成为电动汽车时代的加"电"站
- 雷索纳斯激活码大全最新
- 4 Destination Marketing Campaigns to Inspire You In 2024 and Beyond • Regiondo
- 日恶意滋扰辽宁舰编队,与越南有什么关系?
- 卓锦股份董事长和副总被取保候审,正常履职
- 美国:垃圾分类实现城镇全覆盖
- 《科学》杂志评出2025年度十大突破
- F1与摩纳哥大奖赛续约至2035年







